Google News – FDA (biotech/pharma) External News
Life Sciences & Pharma Articles
Google News – Pharmaceuticals External News
Which Healthcare ETF Is the Better Buy: Fidelity's Broad FHLC or State Street's Pharma-Focused XPH? - The Motley Fool
Google News – Pharmaceuticals External News
Quoin Pharmaceuticals Releases New NETHERTON NOW Video: Aminah’s Story Featuring Laura Wright-Sexton, MD, the Physician Who First Met Her Daughter in the ICU - The Manila Times
Google News – Pharmaceuticals External News
A doctor met a critically ill baby in the ICU, then adopted her - Stock Titan
Google News – Clinical Trials External News
Could UK clinical trial revamp unlock closer ties with Canada? - pharmaphorum
Google News – Clinical Trials External News
BioMarin paints picture of dwarfism drug’s wider efficacy on Phase III win - Clinical Trials Arena
Google News – Pharmaceuticals External News
Verrica Pharmaceuticals to Present YCANTH® and VP-315 Data at Two Upcoming Dermatology Conferences - The Manila Times
Google News – Biopharma External News
$AEON Biopharma (AEON.US)$ interesting. got it marked from 2025 not sure why lmao - moomoo.com
Google News – Pharmaceuticals External News
Verrica Pharmaceuticals to Present YCANTH® and VP-315 Data at Two Upcoming Dermatology Conferences - Yahoo Finance
Google News – Pharmaceuticals External News
Glenmark Pharmaceuticals and South Piedmont Community College Launch Aseptic Training Facility in Monroe, N.C. - PR Newswire
Google News – Pharmaceuticals External News
Retension Pharmaceuticals Appoints LeAnne Bloedon, M.S., RD, as EVP of Clinical Development and Operations, and Kevin Schutz, PharmD, as VP Regulatory Affairs - Business Wire
Google News – Clinical Trials External News
Retension Pharmaceuticals Appoints LeAnne Bloedon, M.S., RD, as EVP of Clinical Development and Operations, and Kevin Schutz, PharmD, as VP Regulatory Affairs - Yahoo Finance
Google News – Pharmaceuticals External News
Rhythm Pharmaceuticals Announces New Data Presentations at the European Society for Paediatric Endocrinology Meeting - Yahoo Finance
Google News – Pharmaceuticals External News
Faruqi & Faruqi, LLP Urges Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Investors to Seek Counsel Before the September 14, 2026 Lead Plaintiff Deadline in the Securities Class Action - PR Newswire
Google News – Pharmaceuticals External News